“It’s a hiccup that won’t help the vaccine’s reputation, it won’t help encourage people to do AstraZeneca, even those over 60.” So Andrea Crisanti, director of the Molecular Medicine Department of the University of Padua, guest of Lilli Gruber at ‘Otto e mezzo’ on La7, on the case of the 18-year-old Ligurian who died of a thrombosis, a few days after getting the AstraZeneca vaccine. Read also “It is an episode that in my opinion occurred for two reasons: first because what were the original indications of the CTS were disregarded and that is that AstraZeneca should preferably be done only to people over 60 years – underlines the expert – Preferably it means that in the absence of alternatives this must be done. Since there were alternatives, it was wrong to do this vaccine “. “Then there is the fact, I read, that the girl suffered from an important coagulation defect – continues Crisanti – and among other things she also did hormone therapy. So she was a person who in any case should not have been subjected to the AstraZeneca vaccine. “. “I wonder how it was possible that he escaped all these links – he continues – first the fact that this vaccine should not have been done in general, given that we had Moderna and then, in this specific case, how was it possible that a person who she had a bleeding defect, which is known to be somehow associated with a complication, she was vaccinated with AstraZeneca. If you do these things, you do incredible damage to the vaccination and offer a fantastic weapon to the no vaxes. ”
Welcome! Log into your account
Recover your password
A password will be e-mailed to you.